Merck & CompanyvsDr. Reddy's Laboratories

MRK and RDY stock compared: price, dividend, valuation and results, from SEC filings.

MRK

Merck & Company, Inc.

$133.72

Value $331B

+0.69%
MRK's page

RDY

Dr. Reddy's Laboratories Ltd

$14.89

Value $12.4B

+0.40%
RDY's page

Merck & Company (MRK) has a market value of $331B and Dr. Reddy's Laboratories (RDY) $12.4B. Over the last year, with dividends, MRK moved +44.8% and RDY +6.7%. The P/E is 134.8 for MRK and 27.2 for RDY. Dividend yield: MRK 2.54%, RDY 0.57%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    MRK$331B

    RDY$12.4B

    MRK is 27 times RDY

  • Revenue, 12 months

    MRK$67.4B

    RDY$3.6B

    MRK is 19 times RDY

  • Net income, 12 months

    MRK$2.5B

    RDY$457M

    MRK is 5.4 times RDY

  • Operating margin

    MRK–

    RDY15.0%

  • ROIC

    MRK3.9%

    RDY8.8%

    4.9 points apart

  • P/E

    MRK134.8

    RDY27.2

    MRK is 5.0 times RDY

  • Dividend yield

    MRK2.5%

    RDY0.6%

    1.9 points apart

  • 5-year return

    MRK+93.0%

    RDY+25.3%

    67.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

MRK+93.0%

RDY+25.3%

10015020020222023202420252026
Returns by period
PeriodMRKWith dividendsRDYWith dividends
1 year since November 19, 2025+44.8%Price +40.7%+6.7%Price +6.0%
3 years since November 20, 2023+42.7%+12.6% a yearPrice +30.2%+12.4%+4.0% a yearPrice +10.3%
5 years since November 19, 2021+93.0%+14.1% a yearPrice +65.7%+25.3%+4.6% a yearPrice +19.4%
10 years since November 21, 2016+205.2%+11.8% a yearPrice +124.9%+78.7%+6.0% a yearPrice +63.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

MRKMerck & CompanyRDYDr. Reddy's Laboratories

Valuation

MRKRDY
Valuation
Price$133.72$14.89
Market value$331B$12.4B
Enterprise value (EV)$375B$13.0B
P/E134.827.2
P/E, 5-year median14.818.3
P/B7.43.1
EV/EBIT78.724.2
Free cash flow yield4.5%2.9%

Results and growth

MRKRDY
Results and growth
Revenue, 12 months$67.4B$3.6B
Net income, 12 months$2.5B$457M
Free cash flow, 12 months$14.7B$356M
Earnings per share, 12 months$0.98$0.55
Revenue growth, year on year1.3%3.2%
Revenue growth a year, past+9.4%over 5 years+12.1%over 5 years
EPS growth a year, past+21.2%over 5 years+19.9%over 5 years

Margins and returns on capital

MRKRDY
Margins and returns on capital
Gross margin71.8%52.8%
Operating margin–15.0%
Net margin3.6%12.8%
ROIC3.9%8.8%
ROE5.2%11.3%

Balance sheet

MRKRDY
Balance sheet
Cash$9.7B$164M
Total debt$53.8B$760M
Net debt / EBITDA5.70.8
Interest cover2.4×–

Dividends and buybacks

MRKRDY
Dividends and buybacks
Dividend yield2.5%0.6%
Dividend per share, 12 months$3.40$0.09
Dividend growth a year, past+5.8%over 5 years+4.5%over 5 years
Buyback yield1.5%–
Shareholder yield4.1%0.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: MRK or RDY

Didn't find what you were looking for?

Ask us
Which is bigger, Merck & Company or Dr. Reddy's Laboratories?

By market value, Merck & Company ($331B) is about 26.6 times Dr. Reddy's Laboratories ($12.4B), at today's prices.

How did MRK and RDY stock do over the last 10 years?

Since November 21, 2016, MRK's price moved +124.9% and RDY's +63.6%. With dividends: MRK +205.2% (+11.8% a year), RDY +78.7% (+6.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, MRK or RDY?

The dividend yield at today's price is 2.54% for Merck & Company and 0.57% for Dr. Reddy's Laboratories. Over the last twelve months they paid $3.40 and $0.09 per share.

What is the P/E of MRK and RDY?

At today's price, the P/E is 134.8 for MRK and 27.2 for RDY. The median of the last five years was 14.8 and 18.3, which shows where each stands against its own past.

Which has the higher profit margins, Merck & Company or Dr. Reddy's Laboratories?

Over the last twelve months, the net margin was 3.6% for Merck & Company and 12.8% for Dr. Reddy's Laboratories, and the operating margin – and 15.0%. Revenue was $67.4B and $3.6B.

Which is the better investment, Merck & Company or Dr. Reddy's Laboratories?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.